UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Advances in sarcoma diagnostics and treatment

Oncotarget, 2017-01, Vol.8 (4), p.7068-7093

2017

Volltextzugriff (PDF)

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications

Journal of experimental & clinical cancer research, 2022-09, Vol.41 (1), p.1-265, Article 265

2022

Volltextzugriff (PDF)

Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication

Breast cancer (Tokyo, Japan), 2017-01, Vol.24 (1), p.3-15

2017

Volltextzugriff (PDF)

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer

Breast cancer research : BCR, 2012-03, Vol.14 (2), p.R48-R48, Article R48

2012

Volltextzugriff (PDF)

Metastatic Behavior of Breast Cancer Subtypes

Journal of clinical oncology, 2010-07, Vol.28 (20), p.3271-3277

2010

Volltextzugriff (PDF)

Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy

Cancer discovery, 2015-02, Vol.5 (2), p.124-134

2015

Volltextzugriff (PDF)

Breast Cancer Subtypes and the Risk of Local and Regional Relapse

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1684-1691

2010

Volltextzugriff (PDF)

Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

Journal of clinical oncology, 2013-01, Vol.31 (2), p.203-209

2013

Volltextzugriff (PDF)

Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes

Nature communications, 2022-02, Vol.13 (1), p.896-19, Article 896

2022

Volltextzugriff (PDF)

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

Clinical cancer research, 2008-03, Vol.14 (5), p.1368-1376

2008

Volltextzugriff (PDF)

Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas

Oncoimmunology, 2020-01, Vol.9 (1), p.1747340

2020

Volltextzugriff (PDF)

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1160-1167

2009

Volltextzugriff (PDF)

Sox10 and S100 in the diagnosis of soft-tissue neoplasms

Applied immunohistochemistry & molecular morphology, 2012-10, Vol.20 (5), p.445-450

2012

Volltextzugriff (PDF)

Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type

The Journal of pathology, 2016-02, Vol.238 (3), p.389-400

2016

Volltextzugriff (PDF)

deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data

PLoS computational biology, 2011-05, Vol.7 (5), p.e1001138-e1001138

2011

Volltextzugriff (PDF)

Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1168-1176

2009

Volltextzugriff (PDF)

The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma

Cancer cell, 2018-03, Vol.33 (3), p.527-541.e8

2018

Volltextzugriff (PDF)

New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype

Clinical cancer research, 2015-11, Vol.21 (21), p.4753-4759

2015

Volltextzugriff (PDF)

The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer

Breast cancer research : BCR, 2018-07, Vol.20 (1), p.79-79, Article 79

2018

Volltextzugriff (PDF)

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

BMC cancer, 2007-07, Vol.7 (1), p.134-134, Article 134

2007

Volltextzugriff (PDF)

Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers

Journal of clinical oncology, 2008-12, Vol.26 (35), p.5697-5704

2008

Volltextzugriff (PDF)

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

JAMA : the journal of the American Medical Association, 2006-06, Vol.295 (21), p.2492

2006

Volltextzugriff (PDF)

Deconstruction of the SS18-SSX Fusion Oncoprotein Complex: Insights into Disease Etiology and Therapeutics

Cancer cell, 2012-03, Vol.21 (3), p.333-347

2012

Volltextzugriff (PDF)

HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma

PloS one, 2017-01, Vol.12 (1), p.e0169407-e0169407

2017

Volltextzugriff (PDF)

TIM-3 expression in breast cancer

Oncoimmunology, 2018-11, Vol.7 (11), p.e1502128-e1502128

2018

Volltextzugriff (PDF)

1 – 25 von 318

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(301)
Mit Volltextzugriff
(285)

Publikationsform

Sprache

Englisch
(318)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Advances in sarcoma diagnostics and treatment

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications

Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer

Metastatic Behavior of Breast Cancer Subtypes

Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy

Breast Cancer Subtypes and the Risk of Local and Regional Relapse

Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

Sox10 and S100 in the diagnosis of soft-tissue neoplasms

Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type

deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data

Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma

New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype

The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

Deconstruction of the SS18-SSX Fusion Oncoprotein Complex: Insights into Disease Etiology and Therapeutics

HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma

TIM-3 expression in breast cancer

Suchergebnisse filtern